These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 26909859)

  • 41. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action.
    Zhang X; Chen J; Weng Z; Li Q; Zhao L; Yu N; Deng L; Xu W; Yang Y; Zhu Z; Huang H
    Mol Immunol; 2020 Mar; 119():48-58. PubMed ID: 31978707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo.
    Tang Q; Nagaya T; Liu Y; Lin J; Sato K; Kobayashi H; Chen Y
    J Control Release; 2017 Aug; 260():154-163. PubMed ID: 28601576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model.
    Sato K; Nagaya T; Nakamura Y; Harada T; Choyke PL; Kobayashi H
    Oncotarget; 2015 Aug; 6(23):19747-58. PubMed ID: 25992770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer.
    Ishida M; Kagawa S; Shimoyama K; Takehara K; Noma K; Tanabe S; Shirakawa Y; Tazawa H; Kobayashi H; Fujiwara T
    Mol Cancer Ther; 2016 Mar; 15(3):402-11. PubMed ID: 26832799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HER2 targeting near-infrared photoimmunotherapy for a CDDP-resistant small-cell lung cancer.
    Takahashi K; Taki S; Yasui H; Nishinaga Y; Isobe Y; Matsui T; Shimizu M; Koike C; Sato K
    Cancer Med; 2021 Dec; 10(24):8808-8819. PubMed ID: 34729945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.
    Phillips GD; Fields CT; Li G; Dowbenko D; Schaefer G; Miller K; Andre F; Burris HA; Albain KS; Harbeck N; Dieras V; Crivellari D; Fang L; Guardino E; Olsen SR; Crocker LM; Sliwkowski MX
    Clin Cancer Res; 2014 Jan; 20(2):456-68. PubMed ID: 24097864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor 2-positive gastric cancer.
    Xiong J; Han S; Ding S; He J; Zhang H
    Oncol Rep; 2018 Mar; 39(3):1396-1404. PubMed ID: 29328489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
    Kiss B; van den Berg NS; Ertsey R; McKenna K; Mach KE; Zhang CA; Volkmer JP; Weissman IL; Rosenthal EL; Liao JC
    Clin Cancer Res; 2019 Jun; 25(12):3561-3571. PubMed ID: 30890547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.
    Hamano S; Mori Y; Aoyama M; Kataoka H; Tanaka M; Ebi M; Kubota E; Mizoshita T; Tanida S; Johnston RN; Asai K; Joh T
    Cancer Lett; 2015 Jan; 356(2 Pt B):846-54. PubMed ID: 25444894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate.
    Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X
    Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.
    Kishimoto S; Oshima N; Yamamoto K; Munasinghe J; Ardenkjaer-Larsen JH; Mitchell JB; Choyke PL; Krishna MC
    Free Radic Biol Med; 2018 Feb; 116():1-10. PubMed ID: 29289705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer.
    Yamaguchi H; Pantarat N; Suzuki T; Evdokiou A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer.
    Isobe Y; Sato K; Nishinaga Y; Takahashi K; Taki S; Yasui H; Shimizu M; Endo R; Koike C; Kuramoto N; Yukawa H; Nakamura S; Fukui T; Kawaguchi K; Chen-Yoshikawa TF; Baba Y; Hasegawa Y
    EBioMedicine; 2020 Feb; 52():102632. PubMed ID: 31981983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody.
    Huang S; Li F; Liu H; Ye P; Fan X; Yuan X; Wu Z; Chen J; Jin C; Shen B; Feng J; Zhang B
    MAbs; 2018; 10(6):864-875. PubMed ID: 30081724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies?
    Watanabe R; Hanaoka H; Sato K; Nagaya T; Harada T; Mitsunaga M; Kim I; Paik CH; Wu AM; Choyke PL; Kobayashi H
    J Nucl Med; 2015 Jan; 56(1):140-4. PubMed ID: 25500827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
    Polikarpov DM; Campbell DH; Lund ME; Lu Y; Lu Y; Wu J; Walsh BJ; Zvyagin AV; Gillatt DA
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():102064. PubMed ID: 33069874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.
    Arpino G; Gutierrez C; Weiss H; Rimawi M; Massarweh S; Bharwani L; De Placido S; Osborne CK; Schiff R
    J Natl Cancer Inst; 2007 May; 99(9):694-705. PubMed ID: 17470737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.